Position in JNJ
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$9,829,400
+$384,972 QoQ
Shares Held
38,703
+0.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
#1,122
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rehmann Capital Advisory Group holds $37,318,224 across 12 Drug Manufacturers - General names. JNJ ranks #1 (26.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
38,703 | $9,829,400 | |
| 2 | LLY |
ELI LILLY & Co
|
5,246 | $6,292,210 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,611 | $3,805,013 | |
| 4 | PFE |
Pfizer Inc
|
152,066 | $3,661,749 | |
| 5 | ABBV |
AbbVie Inc.
|
12,987 | $3,268,048 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,344 | $2,439,861 | |
| 7 | AMGN |
Amgen Inc
|
6,083 | $2,202,775 | |
| 8 | AZN |
Astrazeneca PLC
|
10,283 | $1,949,862 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,829,400 | 38,703 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $9,444,428 | 38,637 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,756,675 | 42,313 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $7,303,508 | 39,389 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,108,014 | 39,987 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $6,818,677 | 41,116 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $6,391,770 | 44,197 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,069,867 | 43,625 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $6,628,794 | 45,353 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,568,365 | 41,522 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $6,661,293 | 42,499 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,761,419 | 43,412 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,349,750 | 44,404 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $6,930,980 | 44,716 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,960,732 | 45,065 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $7,579,904 | 46,400 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,640,562 | 43,043 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,733,962 | 43,638 | Shares | Sole | 2022-06-03 | |
| 2021-12-31 | $7,363,708 | 43,045 | Shares | Sole | 2022-03-02 | |
| 2021-09-30 | $6,734,065 | 41,697 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $6,704,259 | 40,696 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,603,747 | 40,181 | Shares | Sole | 2021-05-26 | |
| 2020-12-31 | $6,249,402 | 39,709 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $5,199,634 | 34,925 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $4,903,768 | 34,870 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $4,458,682 | 34,002 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||